Assessing the risk of recurrent thrombosis and the Vienna Prediction Model

2015-06-05

James Douketis

See also

Management tips for use of the new oral anticoagulants Prof. James Douketis, from McMaster University, Canada, addresses real-world "what if" scenarios for managing patients on NOACs, such as how to choose the right NOAC, determine if a patient needs a procedure or surgery, understand safety of concomitant drugs, and prescribe off-label use of NOACs.
An association between novel oral anticoagulants, acute coronary syndromes, and the risk of myocardial infarction Is there an association between novel oral anticoagulants, acute coronary syndromes, and the risk of myocardial infarction?

We would love to hear from you

Comments, mistakes, suggestions?